TOKYO, May 8, 2025 – FUJIFILM Holdings Corporation announced today financial results for the full fiscal year ended March 31, 2025. For the fiscal year, revenue increased by 7.9% year-over-year to JPY3,195.8 billion. This growth was primarily supported by robust performance in the Electronics and Imaging businesses, and the favorable impact of exchange rates. Operating income rose 19.3% year-over-year to JPY330.2 billion, driven by revenue growth and currency effects. Net income attributable to FUJIFILM Holdings increased by 7.2% year-over-year to JPY261.0 billion.
For the fiscal year ending March 31, 2026, the company projects record-high financial performance, with revenue of JPY3,280 billion driven by the commencement of operations at new large-scale Bio CDMO facilities. Operating Income is expected to grow 9.4% year-on-year, excluding one-time gains from asset sales and foreign exchange effects from the previous fiscal year, to reach JPY331.0 billion. Net income attributable to FUJIFILM Holdings is forecasted JPY262.0 billion. This outlook does not account for potential impacts of U.S. tariff policies.
The annual dividend for the fiscal year ended March 31, 2025, is forecasted at JPY65 per share, aligning with the company’s 15th consecutive annual dividend increase. For the fiscal year ending March 31, 2026, the dividend is projected to increase further to JPY70 per share.
“We are pleased to announce record-high revenue, operating income, and net income for the fiscal year ended March 31, 2025, the first year of our medium-term management plan, VISION2030,” says Teiichi Goto, president and chief executive officer, representative director, FUJIFILM Holdings Corporation. “These results were driven by strong performance in semiconductor materials within the Electronics segment, and solid growth in the Imaging segment, including the instax™ series and the X and GFX series digital cameras. Building on this momentum, our focus for the current fiscal year is to achieve continued growth by further expanding in the areas such as semiconductor materials for generative AI, and scaling operations in the Bio CDMO business. We are committed to accelerating progress towards the goals outlined in VISION2030 and establishing Fujifilm as a collection of global leading businesses.”
In the fourth quarter, revenue increased by 7.8% year-over-year to JPY868.3 billion. Operating income was JPY106.9 billion, increasing by 48.9% year-over-year. Net income attributable to FUJIFILM Holdings increased by 13.9% to JPY79.4 billion.
- Revenue increased by 9.0% year-over-year to JPY310.0 billion and operating income grew by 20.6% year-over-year to JPY44.8 billion.
- In the Medical Systems business, revenue growth was driven by strong sales of endoscopes in Japan, the United States, Europe, and China, as well as robust performance of IVD (In-Vitro Diagnostics) products and medical IT products and services.
- In the Bio CDMO business, revenue rose 18.1% year-over-year to JPY73.0 billion, bolstered by contributions from the new facility in Denmark, which features large-scale tanks.
- In the Life Sciences Solutions business, revenue experienced a decline due to the absence of licensing income from BlueRock Therapeutics LP for an iPS cell-based eye disease treatment program, which had been recorded in the previous year.
- Revenue increased by 3.9% year-over-year to JPY106.6 billion and operating income grew by 41.7% year-over-year to JPY18.2 billion.
- In the Electronic Materials business, revenue increased by 3.2% year-over-year, driven by strong demand for advanced semiconductor materials used in generative AI.
- In the Advanced Functional Materials business, revenue increased by 4.8% year-over-year due to strong sales of display materials, as well as growth in materials for semiconductors and consumer electronics components in the electronics market.
- Revenue increased by 6.0% year-over-year, reaching JPY336.4 billion, and operating income rose by 68.6% year-over-year, amounting to JPY31.9 billion.
- In the Business Solutions business, revenue growth was primarily driven by increased sales of services provided to municipalities and solutions related to digital transformation.
- The Office Solutions business achieved higher revenue thanks to increased sales of multifunctional printers in Europe and the United States.
- In the Graphic Communications business, revenue decreased due to weaker demand for inkjet heads in the ceramic market, stemming from the sluggish performance of China’s real estate sector.
- Strong sales in instant photo systems and digital cameras drove revenue up by 14.1% year-over-year to JPY115.3 billion and operating income surged 1.9 times from the previous year to JPY24.2 billion.
- In the Consumer Imaging business, steady demand for instax™ instant photo systems contributed to the increase in revenue.
- In the Professional Imaging business, sales of digital cameras grew in China and Europe. The continued strong performance of last year’s digital cameras releases, including the X100VI, GFX100S II, X-T50 and X-M5 further bolstered overall sales.
For more details, please visit the Investor Relations section of Fujifilm website
FUJIFILM Holdings Corporation
Corporate Communications Division, Public Relations Group
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.